GE Healthcare DeepHealth, a RadNet subsidiary, announced a collaboration on new AI imaging technologies to accelerate innovation, commercialization, and adoption of AI in imaging.
The companies are leveraging the power of AI to address key roadblocks across the imaging value chain, including helping improve the efficiency of image interpretation and reporting, enabling collaboration between medical teams, improving clinical interpretation of images, and enhancing operations. We plan to jointly develop smart technology, a solution that will be utilized. efficiency and productivity.
SmartTechnology brings together GE HealthCare's imaging capabilities and enhanced capabilities, RadNet's healthcare delivery experience, and DeepHealth's AI-powered medical informatics portfolio to improve end-to-end clinical and operational workflows.
GE Healthcare and RadNet will initially work to combine DeepHealth's AI-based SmartMammo workflow and clinical solution with GE Healthcare's patient-centric Senographe Pristina mammography system to provide AI-powered clinical imaging support for breast cancer screening. .
GE HealthCare's Senographe Pristina mammography system is used to ease patient anxiety in the exam room.
The partnership will also enable GE Healthcare to distribute SmartMammo and other DeepHealth solutions to U.S. imaging providers as part of its broader portfolio of imaging technologies.
“We are excited to work with GE Healthcare to accelerate the adoption of AI-powered technologies in radiology,” said Kees Wesdorp, president and CEO of RadNet's digital health division, in a statement. “There is,” he said.
“Combining our pioneering cloud-native operating system, DeepHealth OS, and our AI-powered health information portfolio with GE HealthCare’s cutting-edge imaging technology, we are revolutionizing large-scale diagnostic and screening programs and delivering This collaboration will provide healthcare providers with the tools they need to deliver more effective, personalized care at scale. The purpose is
Roland Lott, President and CEO of GE Healthcare's Imaging Division, said the company has a tradition of innovation in imaging and AI and is developing new technologies that push the boundaries of what is possible to enable precision care. He stated that he is committed to continuous pursuit of technology.
“This new partnership with DeepHealth leverages our collective strengths to address the critical challenges in today's healthcare,” Lott said in a statement.
“As we strive to achieve more personalized, patient-centered breast care, AI is making a difference in breast cancer screening, from early detection and risk prediction to reduced callbacks and more efficient workflows for breast imaging providers. We continue to show great promise as we combine the power of image processing and AI to improve personalized breast care for people facing this difficult diagnosis.”
bigger trends
October, GE Healthcare CareIntellect for Oncology is a cloud application that leverages generative AI to combine multimodal patient data from disparate systems into a single view, giving clinicians access to notes and reports.
The application also displays pertinent data to help the medical team understand disease progression and identify potential deviations from the treatment plan, allowing clinicians to determine possible next steps and proactively Helps inform interventions. The app will initially target prostate cancer and breast cancer. It is expected to be available next year.
In July, GE Healthcare and Amazon Web Services (AWS) forms a strategic partnership to build AI workflows using AWS healthcare and genAI services to improve diagnostic screening accuracy, streamline healthcare operations, and advance equitable care. contributed to improved access and outcomes. GE said it will use Amazon Bedrock's underlying models to create its own genAI applications and modernize applications built on Amazon SageMaker.
In June, GE Healthcare and MediView XR announced the first successful clinical use of its co-developed OmnifyXR Interventional Suite System.
OmnifyXR combines GE's imaging technology with MediView's AR and surgical navigation platform to help physicians better understand patient anatomy and make more informed clinical decisions. , enables remote collaboration by medical teams in different locations.
In 2022, Volpara Health Technologies has signed an agreement with RadNet to deploy Volpara Analytics and Volpara Risk Pathways software across RadNet's 353 imaging centers in seven U.S. states.
